pound, mp 182 -186°C after crystallization from methanol-water,
[a]' D'+16.1' (c 2.1, MeOH). The FDMS techniquelbl recently developed in this laboratory of cationization using alkali metal salts indicated that 1,653 is the molecular weight of antiamoebin II: by adding a methanolic solution of sodium chloride the molecular ion moved up by 23 amu to m/e 1,676 and by adding potassium chloride it appeared at m/e 1,692. Microanalyses agreed with the molecular formula C82H127N17019.2H20 (1,653+2H20).
Vigorous hydrolysis of antiamoebin II (6 N HC1, 110± 1 °C, 24 hours) yielded a mixture which when analyzed by FDMS, showed M+H ions at m/e 76 (glycine, Gly, cf. seq.), 104 (a-aminoisobutyric acid, Aib), 116 (proline, Pro), 118 (isovaline, a-amino-a-methyl butyric acid, Iva), 132 (hydroxyproline and/or leucine, Hyp and/or Leu), 148 (glutamic acid, Glu), 152 (phenylalaninol, Phol), and 166 (phenylalanine, Phe). Quantitation of these hydrolysis products by gas chromatography (GC) as their N-TFA n-butyl ester derivatives' '7' and comparison of the GC chromatograms of antiamoebins I and II clearly revealed ( PhoI   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 2: The IR spectrum (KBr) of antiamoebin II showed bands at 3440, 1660, and 1540 cm-' (amide) and the 1H NMR spectrum (DMSO-d6) a characteristic acetyl signal at 1.84 ppm (s, 3H). Since, like antiamoebin I, it analyzes for one -CONH2 group per mole , antiamoebin II must also be linear, with N-terminal acetyl, Gin, and C-terminal Phol units.
The electron impact (EI) mass spectrum of antiamoebin II showed characteristic ions at »t/e 884, 799, 714, 601, 544, 445, 360, and 275, indicating partial structure a in antiamoebin 11, A portion of the oligopeptide mixture from partial acid hydrolysis was also derivatized as described earlier"" to N-TFA n-butyl ester derivatives and analyzed by GC and GC'-MS. Again, no Hyp-Aib was observed, but a peak due to Pro-Aib was present.
Based on the above evidence and on biogenetic considerations structure 2 is assigned to antiamoebin II. 
